$0.00786
0.0026651.15%
At close: -
Comments
Loading...
Accelerate Diagnostics Analyst Ratings and Price Targets | OTC:AXDXQ | Benzinga
Accelerate Diagnostics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Accelerate Diagnostics Corp from these most-recent analyst ratings.
Analyst Ratings for Accelerate Diagnostics
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Accelerate Diagnostics (AXDXQ) stock?
There is no price target for Accelerate Diagnostics
What is the most recent analyst rating for Accelerate Diagnostics (AXDXQ)?
There is no analyst for Accelerate Diagnostics
When was the last upgrade for Accelerate Diagnostics (AXDXQ)?
There is no last upgrade for Accelerate Diagnostics
When was the last downgrade for Accelerate Diagnostics (AXDXQ)?
There is no last downgrade for Accelerate Diagnostics.
When is the next analyst rating going to be posted or updated for Accelerate Diagnostics (AXDXQ)?
There is no next analyst rating for Accelerate Diagnostics.
Is the Analyst Rating Accelerate Diagnostics (AXDXQ) correct?
There is no next analyst rating for Accelerate Diagnostics.
Browse analyst ratings and price targets on all stocks.
